Bio Place

Latest Medical, Biological, and Genomic News!


icon

Eli Lilly's donanemab modestly slows Alzheimer's

"Both donanemab and lecanemab bind to various forms of beta amyloid in the brain and are intended to promote their clearance from the extracellular deposits knowns as plaques."
Science
2023-05-05 05:40:34